Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-02-10T20:28:36.252Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinically relevant reduction of lamotrigine concentrations by carbamazepine

Published online by Cambridge University Press:  16 April 2020

Horst J. Koch ,
Alexander Szecsey  and
Matthias Vogel
Horst J. Koch*
Affiliation:
Department of Gerontopsychiatry, Psychiatric University Clinic, Universitätsstrasse 84, 93053Regensburg, Germany
Alexander Szecsey
Affiliation:
Department of Gerontopsychiatry, Psychiatric University Clinic, Universitätsstrasse 84, 93053Regensburg, Germany
Matthias Vogel
Affiliation:
Department of Gerontopsychiatry, Psychiatric University Clinic, Universitätsstrasse 84, 93053Regensburg, Germany
*
*Corresponding author.
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Short communication
Information
European Psychiatry , Volume 18 , Issue 1 , February 2003 , pp. 42
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ebert, U, Thong, NQ, Oertel, R, Kirch, WEffects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamot-rigine in healthy subjects. Eur J Clin Pharmacol 2000;56:299–304.CrossRefGoogle ScholarPubMed
Hachad, H, Ragueneau-Majlessi, I, Levy, RHNew antiepileptic drugs: review on drug interactions. Ther Drug Monit 2002;24:91–103.CrossRefGoogle ScholarPubMed
Harden, CSafety profile of levetiracetam. Epilepsia 2001;42(Suppl 4):36–9.CrossRefGoogle ScholarPubMed
Janowsky, DS. New treatments of bipolar disorder. Curr Psychiatry Rep 1999;1:111–3.CrossRefGoogle ScholarPubMed
Pihlsgard, M, Eliasson, ESignificant reduction of sertraline plasma levels by carbamazepine and phenytoin. Eur J Clin Pharmacol 2002 [Online 23 January 2002].CrossRefGoogle ScholarPubMed
Shah, MM, Balaran, REffect of phenobarbitone, carbamazepine and sodium valproate on the elimination kinetics of acetaminophen. Indian J Pharmacol 1999;31:311–4.Google Scholar
Willmore, LJ. Lamotrigine. Expert Rev Neurotherapeutics 2001;1: 33–42.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.